1. Home
  2. BIGZ vs EVO Comparison

BIGZ vs EVO Comparison

Compare BIGZ & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIGZ
  • EVO
  • Stock Information
  • Founded
  • BIGZ 2021
  • EVO 1993
  • Country
  • BIGZ United States
  • EVO Germany
  • Employees
  • BIGZ N/A
  • EVO N/A
  • Industry
  • BIGZ
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BIGZ
  • EVO Health Care
  • Exchange
  • BIGZ Nasdaq
  • EVO Nasdaq
  • Market Cap
  • BIGZ 1.7B
  • EVO 1.6B
  • IPO Year
  • BIGZ N/A
  • EVO 2021
  • Fundamental
  • Price
  • BIGZ $8.06
  • EVO $4.44
  • Analyst Decision
  • BIGZ
  • EVO Buy
  • Analyst Count
  • BIGZ 0
  • EVO 2
  • Target Price
  • BIGZ N/A
  • EVO $5.90
  • AVG Volume (30 Days)
  • BIGZ 841.6K
  • EVO 46.1K
  • Earning Date
  • BIGZ 01-01-0001
  • EVO 11-06-2024
  • Dividend Yield
  • BIGZ 8.65%
  • EVO N/A
  • EPS Growth
  • BIGZ N/A
  • EVO N/A
  • EPS
  • BIGZ N/A
  • EVO N/A
  • Revenue
  • BIGZ N/A
  • EVO $866,665,179.00
  • Revenue This Year
  • BIGZ N/A
  • EVO $3.84
  • Revenue Next Year
  • BIGZ N/A
  • EVO $10.94
  • P/E Ratio
  • BIGZ N/A
  • EVO N/A
  • Revenue Growth
  • BIGZ N/A
  • EVO N/A
  • 52 Week Low
  • BIGZ $6.21
  • EVO $2.85
  • 52 Week High
  • BIGZ $8.35
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • BIGZ 50.17
  • EVO 49.82
  • Support Level
  • BIGZ $8.03
  • EVO $4.40
  • Resistance Level
  • BIGZ $8.16
  • EVO $4.49
  • Average True Range (ATR)
  • BIGZ 0.10
  • EVO 0.10
  • MACD
  • BIGZ -0.03
  • EVO -0.00
  • Stochastic Oscillator
  • BIGZ 36.11
  • EVO 38.46

About BIGZ BlackRock Innovation and Growth Term Trust of Beneficial Interest

BlackRock Innovation & Growth Tr is a non-diversified, closed-end management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust's adviser focuses on mid- and small-capitalization growth companies that are "innovative.".

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: